Ballast Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.41M | Buy |
58,636
+15,304
| +35% | +$400K | 0.27% | 63 |
|
|
2026
Q1 | $1.22M | Buy |
43,332
+714
| +2% | +$19K | 0.28% | 63 |
|
|
2025
Q4 | $1.06M | Buy |
42,618
+1,734
| +4% | +$43.7K | 0.25% | 65 |
|
|
2025
Q3 | $1.04M | Sell |
40,884
-321
| -0.8% | -$7.92K | 0.25% | 67 |
|
|
2025
Q2 | $999K | Buy |
41,205
+9,272
| +29% | +$216K | 0.26% | 64 |
|
|
2025
Q1 | $809K | Sell |
31,933
-215
| -0.7% | -$5.63K | 0.23% | 68 |
|
|
2024
Q4 | $853K | Buy |
32,148
+4,398
| +16% | +$119K | 0.24% | 66 |
|
|
2024
Q3 | $803K | Buy |
27,750
+502
| +2% | +$14.6K | 0.23% | 65 |
|
|
2024
Q2 | $762K | Buy |
27,248
+5,318
| +24% | +$146K | 0.23% | 66 |
|
|
2024
Q1 | $609K | Buy |
21,930
+4,917
| +29% | +$136K | 0.19% | 72 |
|
|
2023
Q4 | $490K | Sell |
17,013
-14,342
| -46% | -$434K | 0.17% | 74 |
|
|
2023
Q3 | $1.04M | Buy |
31,355
+3,317
| +12% | +$117K | 0.41% | 42 |
|
|
2023
Q2 | $1.03M | Buy |
28,038
+5,983
| +27% | +$233K | 0.39% | 42 |
|
|
2023
Q1 | $900K | Buy |
22,055
+1,972
| +10% | +$85.2K | 0.37% | 47 |
|
|
2022
Q4 | $1.03M | Sell |
20,083
-721
| -3% | -$34.6K | 0.45% | 38 |
|
|
2022
Q3 | $910K | Buy |
20,804
+59
| +0.3% | +$2.87K | 0.44% | 42 |
|
|
2022
Q2 | $1.09M | Sell |
20,745
-1,839
| -8% | -$93.7K | 0.51% | 38 |
|
|
2022
Q1 | $1.17M | Buy |
22,584
+1,638
| +8% | +$85K | 0.45% | 40 |
|
|
2021
Q4 | $1.24M | Sell |
20,946
-978
| -4% | -$48.5K | 0.48% | 35 |
|
|
2021
Q3 | $942K | Buy |
21,924
+1,928
| +10% | +$85.4K | 0.4% | 39 |
|
|
2021
Q2 | $783K | Buy |
19,996
+3,143
| +19% | +$122K | 0.33% | 46 |
|
|
2021
Q1 | $610K | Buy |
16,853
+4,414
| +35% | +$157K | 0.29% | 53 |
|
|
2020
Q4 | $457K | Sell |
12,439
-1,359
| -10% | -$49.8K | 0.23% | 59 |
|
|
2020
Q3 | $480K | Sell |
13,798
-2,276
| -14% | -$79.8K | 0.27% | 60 |
|
|
2020
Q2 | $498K | Buy |
16,074
+616
| +4% | +$20.9K | 0.31% | 56 |
|
|
2020
Q1 | $478K | Buy |
15,458
+2,077
| +16% | +$70.8K | 0.34% | 50 |
|
|
2019
Q4 | $497K | Buy |
13,381
+1,022
| +8% | +$36.4K | 0.27% | 59 |
|
|
2019
Q3 | $421K | Sell |
12,359
-417
| -3% | -$15.2K | 0.26% | 63 |
|
|
2019
Q2 | $525K | Buy |
12,776
+178
| +1% | +$7.07K | 0.33% | 55 |
|
|
2019
Q1 | $507K | Buy |
12,598
+800
| +7% | +$32K | 0.33% | 54 |
|
|
2018
Q4 | $489K | Sell |
11,798
-2,252
| -16% | -$93.5K | 0.38% | 48 |
|
|
2018
Q3 | $587K | Buy |
14,050
+2,453
| +21% | +$94.4K | 0.4% | 42 |
|
|
2018
Q2 | $399K | Buy |
11,597
+374
| +3% | +$12.8K | 0.31% | 55 |
|
|
2018
Q1 | $378K | Buy |
11,223
+164
| +1% | +$5.64K | 0.3% | 55 |
|
|
2017
Q4 | $380K | Buy |
+11,059
| New | +$377K | 0.32% | 57 |
|
Other funds holding PFE
Ballast Inc's PFE Position: Q2 2026 in Review
Ballast Inc increased its Pfizer (PFE) stake by 35% in Q2 2026, buying an estimated $400K and bringing the position to 58,636 shares worth $1.41M. The position accounts for 0.27% of the portfolio, ranked #63.
Ballast Inc first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ballast Inc held 58,636 shares of Pfizer worth $1.41M as of Q2 2026.
- Ballast Inc bought 15,304 Pfizer shares in Q2 2026, an estimated $400K.
- Pfizer made up 0.27% of Ballast Inc's portfolio in Q2 2026, its #63 holding.
- Ballast Inc first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ballast Inc's 13F filing for Q2 2026, filed 10 Jul 2026.